arcapta neohaler

Frequently asked questions

What does Arcapta Neohaler treat?

Arcapta Neohaler (Indacaterol Maleate) may be used to treat pulmonary emphysema, chronic bronchitis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How is Arcapta Neohaler rated?

pharmaranks gives Arcapta Neohaler a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

Is there a coupon or discount for Arcapta Neohaler?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Arcapta Neohaler. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Arcapta Neohaler?

Arcapta Neohaler is marketed by Novartis. You can see Novartis's full profile, rating, and other products on pharmaranks.

Is Arcapta Neohaler a brand-name or generic drug?

Arcapta Neohaler is a brand-name product with the active ingredient Indacaterol Maleate.

Is Arcapta Neohaler available over the counter?

No. Arcapta Neohaler is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Arcapta Neohaler come in?

Arcapta Neohaler is currently marketed as powder, per the FDA's National Drug Code Directory.

Is Arcapta Neohaler FDA-registered?

Arcapta Neohaler is on record with the U.S. FDA under application number NDA022383. You can verify this on its official FDA label.

Has Arcapta Neohaler been recalled by the FDA?

Arcapta Neohaler has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Arcapta Neohaler safe?

There's no single safe-or-not verdict. pharmaranks gives Arcapta Neohaler a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.